Plante Moran Financial Advisors, LLC Kodiak Sciences Inc. Transaction History

Plante Moran Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$110.45 - $164.47 $99,405 - $148,023	-900 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$60.78 - $154.03 $54,702 - $138,627	900 New	900 $132,000
Q2 2020 Aug 10, 2020	SELL	$42.74 - $66.25 $0 - $0	0 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$38.18 - $73.95 $0 - $0	0 New	0 $0

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $288M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.